Instrument Inactif

Communiqués Milestone Scientific Inc. Other OTC

Actions

US59935P2092

Equipement et technologie médicale avancés

Temps réel estimé Cboe BZX 19:41:58 10/09/2026
0,4330 ^USD	0,00 %

14/08	Transcript : Milestone Scientific Inc., Q2 2026 Earnings Call, Aug 14, 2026
14/08	Milestone Scientific Inc. réaffirme ses prévisions de résultats pour l'exercice clos au 31 décembre 2026	CI

Communiqués

26/08	Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors	AQ
14/08	Milestone Scientific Reports Financial Results for Second Quarter 2026	AQ
06/08	Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call	AQ
04/08	Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System	AQ
15/07	Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026	AQ
01/07	Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY	AQ
25/06	Milestone Scientific Strengthens Board to Support Next Phase of Growth	AQ
27/05	Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures	AQ
14/05	Milestone Scientific Reports Financial Results for First Quarter 2026	AQ
08/05	Milestone Scientific Expands CompuFlo Medical Business with Advisor Program and Growing National Clinical Adoption	AQ
07/05	Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call	AQ
07/05	Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption	AQ
21/04	Milestone Scientific Inc. Completes $2.15 Million Private Placement	AQ
31/03	Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025	AQ
26/03	Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call	AQ
23/02	Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion	AQ
10/02	Loss-of-Resistance Versus Dynamic Pressure-Sensing Technology for Successful Placement of Thoracic Epidural Catheters: A Randomized Clinical Trial	PU
10/02	Milestone Scientific : Cost-minimization analysis of the continuous real-time pressure sensing technology in parturients requesting labor epidural analgesia	PU
10/02	Milestone Scientific : Combination of real-time needle-tip pressure sensing and minimal intensity stimulation limits unintentional intraneural injection during an ultrasound-guided…	PU
10/02	Real-Time Injection Pressure Sensing and Minimal Intensity Stimulation Combination During Ultrasound-Guided Peripheral Nerve Blocks: An Exploratory Observational…	PU
10/02	Milestone Scientific : Analysis of Epidural Waveform to Determine Correct Epidural Catheter Placement After CSE Labor Analgesia	PU
10/02	Injection Pressure Monitoring During Peripheral Nerve Blocks: From Bench to Operating Theatre	PU
06/01	Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry	AQ
13/11	Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025	AQ
13/11	Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call	AQ